FDA Inspection
Rechon Life Science ABRechon Life Science AB – FDA Inspection, Sep 6, 2024
Record Details
This FDA Inspection record concerns Rechon Life Science AB, with an inspection on September 6, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7eaa39d1-9842-4349-8abf-b9462415216b
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1251480
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Rechon Life Science AB
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 17, 2023 | Not classified | Office of Inspections and Investigations | |
| November 27, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 29, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 2, 2016 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| April 29, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Rechon Life Science AB
- FDA Inspection 1201600 - 2023-03-17
- FDA Inspection 1125627 - 2019-11-27
- FDA Inspection 1060687 - 2018-06-29
- FDA Inspection 983550 - 2016-06-02
- FDA Inspection 969057 - 2016-04-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.